Vitamin A Status in Patients With Vocal Fold Leukoplakia
Part of paid clinical trials in Madison, Wisconsin.
- Sponsor
- University of Wisconsin, Madison
- Study ID
- NCT05323292
- Status
- Enrolling By Invitation
Conditions
- Leukoplakia
- Vitamin A
- Vitamin A Deficiency
- Vocal Cord Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This study will determine systemic vitamin A status and lesion histopathology of participants with vocal fold hyperkeratosis resulting in clinical leukoplakia.
Key Dates
- Start date
- Jun 29, 2022
- Status verified
- Dec 2025
- Primary completion
- Jun 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 90 participants (estimated)
Arms
- Arm: Leukoplakia due to hyperkeratosis with dysplasiaBiopsy-confirmed diagnosis of hyperkeratosis with dysplasia.
- Arm: Leukoplakia due to hyperkeratosis with no dysplasiaBiopsy-confirmed diagnosis of hyperkeratosis with no dysplasia.
- Arm: Control groupLaryngoscopy showing no evidence of vocal fold epithelial disease.
Primary Outcome Measure
Vitamin A liver reserves [ Time Frame: 14 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Wisconsin Hospitals and Clinics | Madison | Wisconsin | 53792 | - |
Find similar trials in Madison, WI
By research site
Related Studies
- Pembrolizumab in Treating Participants With LeukoplakiaPHASE2 · Recruiting · Jonsson Comprehensive Cancer Center · La Jolla, California
- Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.PHASE2 · Recruiting · Children's Hospital Medical Center, Cincinnati · Tampa, Florida
- Topical Imiquimod Treatment of Oral DysplasiaPHASE1/PHASE2 · Recruiting · University of Southern California · Los Angeles, California